Le Lézard
Classified in: Health
Subjects: LAW, HSP, BLK

Health Affairs Drops Racial Fellowship Requirements Following Do No Harm Lawsuit


Declaring Victory Over Discrimination, Do No Harm Voluntarily Drops Suit Against Health Affairs

RICHMOND, Va., Jan. 22, 2024 /PRNewswire/ -- Today, Do No Harm announced it voluntarily dropped a lawsuit against Health Affairs' Health Equity Fellowship for Trainees after Health Affairs eliminated its discriminatory racial eligibility requirements.

In September 2022, Do No Harm filed a lawsuit on the grounds that the Health Affairs fellowship requirement was racially discriminatory against white students: Applicants were only eligible if they "identify as American Indian/Alaskan Native, African American/Black, Asian American, Native Hawaiian and other Pacific Islander, and Hispanic/Latino." While the lawsuit was pending, Health Affairs eliminated the unlawful requirement. As Health Affairs no longer considers race in the fellowship, Do No Harm voluntarily dismissed their lawsuit without prejudice.

"We are pleased that Health Affairs has decided to drop its racially discriminatory requirements for their fellowship," said Do No Harm Chairman Dr. Stanley Goldfarb. "Segregation based on race is illegal and Health Affairs has recognized that. Do No Harm will continue to fight divisive and discriminatory ideology in healthcare wherever we can find it."

The withdrawal filing can be found here: https://donoharmmedicine.org/wp-content/uploads/2024/01/DNH-v.-Health-Affairs-Notice-of-Voluntary-Dismissal.pdf
The original lawsuit can be found here: https://donoharmmedicine.org/2022/09/06/were-suing-health-affairs-for-racial-discrimination/

Do No Harm, established in April 2022, has rapidly gained recognition and made significant strides in its mission to safeguard healthcare from ideological threats. With more than 6,000 members, including doctors, nurses, physicians, and concerned citizens across all 50 states and in 14 countries, DNH has achieved more than 4,900 media hits in top-tier publications and garnered widespread attention through numerous broadcast news appearances.

SOURCE Do No Harm


These press releases may also interest you

at 06:30
Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has received 510(k) clearance from the US Food and Drug Administration. Previously sold into the clinical market under an enforcement discretion due...

at 06:17
Local Infusion, a technology-driven provider for patients with chronic autoimmune diseases on specialty infusion therapy, announced the opening of a state-of-the-art infusion center in New Haven, Connecticut. We are excited about our continued...

at 06:05
Revvity, Inc. , today reported financial results for the first quarter ended March 31, 2024. The Company reported GAAP earnings per share of $0.21, as compared to $4.50 in the same period a year ago. GAAP revenue for the quarter was $650 million,...

at 06:00
Theravance Biopharma, Inc. will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm ET (2:00 pm...

at 06:00
Repertoire® Immune...

at 06:00
Akoya Pediatric Dentistry is excited to announce the launch...



News published on and distributed by: